S 2337 | CAS#67608-06-4 | synthetic substrate

MedKoo Cat#: 596873 | Name: S 2337

Description:

WARNING: This product is for research use only, not for human or veterinary use.

S 2337 is a synthetic substrate used to estimate Factor X.

Chemical Structure

S 2337

CAS#67608-06-4

Theoretical Analysis

MedKoo Cat#: 596873

Name: S 2337

CAS#: 67608-06-4

Chemical Formula: C37H52N10O9

Exact Mass: 780.3919

Molecular Weight: 780.88

Elemental Analysis: C, 56.91; H, 6.71; N, 17.94; O, 18.44

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

S 2337; S-2337; S2337;

IUPAC/Chemical Name

piperidin-1-yl (S)-5-((2-(((S)-1-amino-5-guanidino-1-oxopentan-2-yl)(4-nitrophenyl)amino)-2-oxoethyl)amino)-4-((2S,3S)-2-benzamido-3-methylpentanamido)-5-oxopentanoate

InChi Key

WLORUVXXAABSGD-LTYDCPJSSA-N

InChi Code

InChI=1S/C37H52N10O9/c1-3-24(2)32(44-34(51)25-11-6-4-7-12-25)36(53)43-28(18-19-31(49)56-45-21-8-5-9-22-45)35(52)42-23-30(48)46(26-14-16-27(17-15-26)47(54)55)29(33(38)50)13-10-20-41-37(39)40/h4,6-7,11-12,14-17,24,28-29,32H,3,5,8-10,13,18-23H2,1-2H3,(H2,38,50)(H,42,52)(H,43,53)(H,44,51)(H4,39,40,41)/t24-,28-,29-,32-/m0/s1

SMILES Code

N=C(N)NCCC[C@@H](C(N)=O)N(C(CNC([C@H](CCC(ON1CCCCC1)=O)NC([C@H]([C@@H](C)CC)NC(C2=CC=CC=C2)=O)=O)=O)=O)C3=CC=C([N+]([O-])=O)C=C3

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 780.88 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Ahmad SS, Rawala R, Cheung WF, Stafford DW, Walsh PN. The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor-X activation. Biochem J. 1995 Sep 1;310 ( Pt 2):427-31. Erratum in: Biochem J 1995 Dec 15;312(Pt 3):991. PubMed PMID: 7654178; PubMed Central PMCID: PMC1135912. 2: Wagenvoord RJ, Hendrix HH, Kolde HJ, Hemker HC. Development of a rapid and sensitive chromogenic heparin assay for clinical use. Haemostasis. 1993;23(1):26-37. PubMed PMID: 8477906. 3: Hofmann H, Bon C. Blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator. Biochemistry. 1987 Feb 10;26(3):772-80. PubMed PMID: 3552031. 4: Lindhout T, Baruch D, Schoen P, Franssen J, Hemker HC. Thrombin generation and inactivation in the presence of antithrombin III and heparin. Biochemistry. 1986 Oct 7;25(20):5962-9. PubMed PMID: 3790498. 5: Torano AE, Nakamura S, Levin J. Properties of the clotting enzyme responsible for endotoxin-mediated Limulus coagulation. Thromb Res. 1984 Jun 1;34(5):407-17. PubMed PMID: 6377572. 6: van Wijk EM, Smit JL. A chromogenic micro-assay for factor X-activity. Thromb Res. 1984 May 1;34(3):263-8. PubMed PMID: 6549615. 7: Gram J, Jespersen J, Sidelmann J. The assay of factor Xa on a centrifugal analyzer. Thromb Res. 1984 Jan 15;33(2):239-42. PubMed PMID: 6367133. 8: Laharrague P, Leleu T, Poignot JL, Cambus JP, Biermé R. [Monitoring anticoagulant treatment with the KEM-O-MAT 2HP autoanalyzer]. Nouv Rev Fr Hematol. 1983;25(2):107-12. French. PubMed PMID: 6866753. 9: Robijns P, Lijnen HR, Collen D. Amidolytic determination of Factor X in clinical plasma samples. Acta Clin Belg. 1983;38(5):289-94. PubMed PMID: 6659834. 10: Egberg N, Heedman PA. Simplified performance of amidolytic factor X assay. Thromb Res. 1982 Mar 1;25(5):437-40. PubMed PMID: 7071814. 11: Erskine JG, Walker ID, Davidson JF. Maintenance control of oral anticoagulant therapy by an automated chromogenic substrate assay of factor X. Clin Lab Haematol. 1982;4(2):179-86. PubMed PMID: 7116798. 12: van Wijk EM, Jeletich A, ten Cate JW. The application of an automated amidolytic factor X assay in oral anticoagulant treatment. Acta Chir Scand Suppl. 1982;509:117-22. PubMed PMID: 6962614. 13: van Wijk EM, Kahlé LH, ten Cate JW. A rapid manual chromogenic factor X assay. Thromb Res. 1981 Jun 1-25;22(5-6):681-6. PubMed PMID: 7302910. 14: van Wijk EM, Kahlé LH, Wiebosch M, ten Cate JW. Optimization of a mechanized amidolytic factor-X assay; influence of reaction conditions and reagents. Clin Chem. 1981 Jun;27(6):918-21. PubMed PMID: 7237773. 15: Conard J, Gradelet A, Samama M. [Estimation of Stuart factor using a synthetic substitute during oral anticoagulant treatment. Preliminary results (author's transl)]. Ann Biol Clin (Paris). 1981;39(2):81-3. French. PubMed PMID: 7258751. 16: Erskine JG, Walker ID, Davidson JF. Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X. J Clin Pathol. 1980 May;33(5):445-8. PubMed PMID: 7400342; PubMed Central PMCID: PMC1146108.